Scarlet Secures $50 Million Series B Funding to Expand AI Medical Device Certification Services

Scarlet, a London-based organization designated for AI-native medical device certification, has secured $50 million in Series B funding led by Headline with participation from Notion Capital, Atomico, Creandum, Kindred Capital and Entrepreneurs First. The investment will support geographical expansion and technical infrastructure development.

Key details

The funding will enable Scarlet to expand its continuous algorithmic surveillance systems and establish a stronger presence in the United States and APAC regions. The company plans to scale its technical review infrastructure to accommodate growing demand for AI-integrated medical device evaluation.

Why it matters

As artificial intelligence becomes increasingly integrated into medical devices, specialized certification approaches are needed to evaluate safety and effectiveness. Scarlet's expansion addresses a growing market need for expertise in assessing AI-enabled healthcare technologies across major global markets.

Context

The investment reflects increasing recognition of the challenges posed by AI in medical device regulation and the growing demand for specialized evaluation capabilities. Scarlet's model represents one approach to addressing the certification gap for complex AI-integrated healthcare technologies.